Controversy surrounds the molecular identity of mitochondrial K + channels that are important for protection against cardiac ischemia-reperfusion injury. While K Na 1.2 (Kcnt2 gene) is necessary for cardioprotection by volatile anesthetics, electrophysiologic evidence for a channel of this type in mitochondria is lacking. The endogenous physiologic role of a potential mito-K Na 1.2 channel is also unclear. Herein, single channel patch-clamp of 27 independent cardiac mitochondrial inner membrane (mitoplast) preparations from wild type (WT) mice yielded 6 channels matching the known ion-sensitivity, ion-selectivity, pharmacology and conductance properties of K Na 1.2 (slope conductance 138±1 pS). However, similar experiments on 40 preparations from Kcnt2 -/mice yielded zero such channels. The K Na opener bithionol uncoupled respiration in WT but not Kcnt2 -/cardiomyocytes. Furthermore, when oxidizing only fat as substrate, Kcnt2 -/cardiomyocytes and hearts were less responsive to increases in energetic demand. Kcnt2 -/mice also had elevated body fat, but no baseline differences in the cardiac metabolome. These data support the existence of a cardiac mitochondrial K Na 1.2 channel, and a role for cardiac K Na 1.2 in regulating metabolism under conditions of high energetic demand.
Introduction
Numerous strategies for protection of the heart and other organs against ischemia-reperfusion (IR) injury are thought to require activation of K + channels in the mitochondrial inner membrane (for review see (1) ). This includes ischemic preconditioning (IPC), volatile anesthetic preconditioning (APC), and pharmacologic cardioprotection by K + channel activators such as NS-11021, bithionol and diazoxide (2) (3) (4) . Concurrently, several K + channels have been reported in mitochondria including: ATP activated (K ATP ) (5) , small conductance Ca 2+ activated (SK) (6, 7) , and splice variants of large conductance Ca 2+ activated (BK) (8, 9) . However, in only a small number of cases has the molecular (genetic) identity of specific mitochondrial channels involved in cardioprotection been proposed (3, (9) (10) (11) (12) . No K + channels exist in the "MitoCarta" database of verified mitochondrial proteins (13) and no canonical mitochondrial target sequences have been identified in any K + channel genes (1) . As such, mystery surrounds the mechanism(s) of K + channel targeting to mitochondria.
Mammalian Na + -activated-K + (K Na ) channels are encoded by two genes: Kcnt1 (14) and Kcnt2 (15), which produce the K Na 1.1 (Slack/SLO2.2) and K Na 1.2 (Slick/SLO2.1) channels respectively. Both K Na 1.1 and K Na 1.2 channels play important neurologic roles in the termination of seizure progression in epilepsy (16, 17).
Although K Na 1.2 expression has been reported in cardiac tissue (15, 18) , and a generic K Na channel activity has been demonstrated in the cardiac cell membrane (19), notably the Kcnt2 -/mice have no cardiac phenotype (3, 18) . Thus relatively little is known regarding the physiologic role of K Na 1.2 channels in the heart, including their subcellular location. Previously we showed that K Na 1.2 is essential for cardiac APC, with hearts from Kcnt2 -/mice incapable of being protected against IR injury by isoflurane (3) . Additionally, we showed that the K Na opener bithionol (BT) is cardioprotective in WT mice but not Kcnt2 -/mice (3, 20) . Further, both BT and isoflurane activated a K + flux in cardiac mitochondria isolated from WT mice, but not those from Kcnt2 -/mice (3) . These observations led us to hypothesize that a K Na 1.2 channel may exist in cardiac mitochondria.
There is considerable evidence that mitochondrial K + channel activity can lessen the impact of IR injury (1) . less is known about the endogenous physiologic role(s) of mitochondrial K + channels (21) , and in particular mitochondrial K Na channels. Na + enters mitochondria predominantly via a Na + /Ca 2+ exchanger (NCLX) or a Na + /monocarboxylate transporter (MCT), with minor contribution from a Na + /H + exchanger (NHE) (22) . Under conditions of elevated mitochondrial Na + uptake (Ca 2+ overload or cytosolic Na + overload driving excessive NCLX activity, or increased cytosolic Na + -lactate driving Na + uptake via the MCT), matrix Na + may attain levels that can activate K Na channels (23) (24) (25) . K + influx via the K Na would dissipate mitochondrial membrane potential, thereby relieving a driving force both for Ca 2+ uptake and NCLX activity. In effect, a mitochondrial K Na channel acts as a "safety valve" to prevent ionic imbalance bought about by excessive Na + uptake.
Herein, using electrophysiologic techniques (mitoplast patch-clamp) we demonstrate that mitochondria contain a K + channel that matches the known ion-sensitivity, ion-selectivity, pharmacology and conductance properties of K Na 1.2. Bioenergetic studies of WT and Kcnt2 -/hearts and cardiomyocytes also reveal a potential role for cardiac K Na 1.2 in the metabolic response to high energetic demand.
Materials and Methods

Animals
Male and female mice were housed in an AAALAC-accredited pathogen-free facility with water and food available ad libitum. All procedures were locally approved and in accordance with the NIH Guide for the Care and Use of Laboratory Animals (2011 revision). Mice were on a C57BL/6J background for >6 generations and periodically backcrossed to fresh stocks. Mice were bred from Kcnt2 +/parents, and male and females were separated but littermate WT and Kcnt2 -/progeny were maintained in the same cages. Mice were genotyped by tail-clip PCR ( Figure 1A) , with DNA extraction by a Qiagen DNeasy™ Kit (Hilden, Germany) and genotyping by a Kapa Biosystems KAPA2G Kit (Wilmington, MA). Primers used were (5'→ 3') forward -AGGCAGCCATAGCTTTAGAGA and reverse CTCCTCATCGTGTGGTCCTA, yielding amplicons at 822 and 547 bp for WT and Kcnt2 -/respectively. Due to the same personnel handling mice and performing experiments, studies were not blinded to genotype.
Patch Clamp of Mitochondrial Inner Membranes (Mitoplasts)
Following anesthesia (tribromoethanol 200mg/kg ip) the heart from one 8-12 week old mouse was rapidly excised, washed and chopped in ice-cold mitochondrial isolation medium (MIM, in mM: 300 sucrose, 20 Tris, 2 EGTA, pH 7.35 at 4 °C). All steps were performed on ice. Tissue was homogenized (Tissumizer TM , IKA Inc., Wilmington NC) then centrifuged at 700 x g, 5 min. Supernatants were saved and pellets rehomogenized and re-centrifuged. Pooled supernatants were then centrifuged at 10,000 x g, 10 min. The crude mitochondrial pellet was suspended in 0.2 ml MIM and layered over 1.75 ml of 30% osmotically-balanced Percoll™, in a round-bottomed microcentrifuge tube, and centrifuged at 14,000 x g, 1 hr. Two mitochondrial layers were apparent ( Figure 1C ), of which the lower (purified mitochondria) was washed twice by centrifugation. The mitochondrial pellet (~25 µl) was suspended in 0.5 ml swelling buffer (in mM: 30 KCl, 20 HEPES, 1 EGTA, pH 7.2) for 15 min. Centrifugation (1,000 x g, 30 s.) afforded a mitoplast pellet, resuspended in ~20 µl MIM for immediate use in patch-clamp studies (N=27 WT, 40 Kcnt2 -/-).
For mitoplast attached patch-clamp studies, mitoplasts were diluted 1:100 in a bath solution (in mM: 150 KCl, 20 HEPES, 1 EGTA, pH 7.2) and a 10 µl drop was placed on a glass coverslip attached to a custom 3D printed micro-chamber ( Figure 1B ). Electrodes (40-100 M→ ) (Sutter Instruments, Novato CA) were filled with pipette solution (in mM: 150 KCl, 0.025 NaCl, 20 HEPES, 1 EGTA, pH 7.2). The bath was exchanged with buffer additionally containing 40 mM NaCl, or 40mM NaCl and 10 µM bithionol (BT, from stock in DMSO, final DMSO < 0.01% v/v). For excised patch experiments mitoplasts were diluted 1:100 in patch seal buffer (in mM: 60 KCl, 80 K-gluconate, 40 LiCl, 0.025 NaCl, 0.1 CaCl 2 (calculated free), 20 HEPES, 1 EGTA, pH 7.2) Electrodes were filled with pipette solution (in mM: 125 KCl, 15 K-gluconate, 15 LiCl 0.025 NaCl, 20 HEPES, 1 EGTA). Mitoplasts were identified by their round shape and presence of a "cap" structure ( Figure 1C ). After formation of G→ seals, patches were excised and inside-out currents were recorded using an Axopatch 200B amplifier and Clampex10 software (Molecular Devices, Sunnyvale CA). All holding potentials reported are those applied to the patch pipette interior. The electrical connection was made using Ag/AgCl electrodes and an agar 2M KCl salt bridge at the ground electrode. (Note: not all channels yielded currents at all potentials, and seal integrity was often compromised at the extremes of this range). Data was digitized and recorded at 10 kHz and filtered using an 8-pole low pass 2 kHz filter. Patches were recorded under flow (0.1 ml/min.) of: (i) Ca 2+ free patch seal buffer with 0.076 mM sucrose for osmotic balance, (ii) as above, with LiCl replaced with 40 mM NaCl, (iii) further addition of 2.5 µM BT (from stock in DMSO, final DMSO < 0.01% v/v). Although the study of K + channels typically employs gluconate salts to exclude the possibility that measured conductances are due to Clchannels, Clsalts were used herein because K Na 1.2 activity is strongly enhanced in the presence of Cl -(15). All buffers were filtered (0.22 µm) immediately before use. Single channel analysis was performed using Clampfit 10.0 single channel search (Molecular Devices). Dwell times were calculated using "single-channel search" using threshold crossing.
Cardiomyocyte Isolation and Respiration Measurements
Mouse primary adult ventricular cardiomyocytes were isolated by collagenase perfusion as previously described (3) . Cells were step-wise rendered tolerant to 1.8 mM Ca 2+ , and the final pellet suspended in 1 ml MEM (GIBCO cat # 11095-080, supplemented with 1.8 mM, CaCl 2 2.5% FBS and pen/strep). Cell viability and yield were determined using Trypan blue and a hemocytometer. Only preparations with >85% viable rod- 
Ex-vivo Heart Perfusion
Mouse hearts were perfused in constant flow (4ml/min) Langendorff mode as previously described (3).
Krebs-Henseleit buffer (KH, in mM: 118 NaCl, 4.7 KCl, 25 NaHCO 3 , 1.2 MgSO 4 , 1.2 KH 2 PO 4 , and 2.5 CaCl 2 , gassed with 95/5 O 2 /CO 2 , 37 °C) was supplemented with either 5 mM glucose, or 0.1 mM BSA-conjugated palmitate. Left ventricular pressure was measured via a water-filled transducer-linked left ventricular balloon.
Left ventricular and coronary root pressures were monitored and digitally recorded at 1 kHz (DATAQ, Akron OH). After equilibration hearts were treated with isoproterenol (100 nM final) for 5 min.
Electron Microscopy
Hearts were fixed in 4 % paraformldehyde + 2.5 % glutaraldehyde in Millonig's phosphate buffer (0.2 M NaH 2 PO 4 /Na 2 HPO 4 , 0.5 % NaCl, pH 7.4). 1 mm cubes were processed and digitally photographed on a Hitachi 7650 electron microscope. Analysis of images was performed using NIH ImageJ software.
Mitochondrial areas and density were placed in to 11 or 13 bins respectively and the resulting histograms were fitted to a single Gaussian. Form-factor was calculated as 1/((4→ .area)/(perimeter 2 )) and aspect-ratio was calculated as (major axis/minor axis).
Metabolomics
WT and Kcnt2 -/hearts (N=7 per group) were perfused as above in KH buffer supplemented with glucose plus palmitate for 20 min., then freeze-clamped with Wollenberger tongs in liquid N 2 and ground to powder. Samples representing ~50% of each heart (50 mg) were shipped to Metabolon Inc. ( Data for each run were median-normalized. Overall, 527 metabolites were identified, of which 26 (4.9%) were removed due to insufficient replicates, yielding 7014 theoretical individual data points (501 x N=7 x 2 groups). A further 229 outliers (>1 standard deviation from the mean) were removed, representing 3.3 % of the data. Missing values were imputed as weighted medians (26) . Metabolomic data were analyzed using free Metaboanalyst software (27) . In a separate series of experiments, WT and Kcnt2 -/hearts were perfused in KH buffer supplemented with fat as the only carbon source, and adenine nucleotide levels (ATP, ADP, AMP) were measured as previously described (28) . Energy charge was calculated as (ATP+½ADP/(ATP+ADP+AMP).
Immunoblotting
Sample protein was determined by the Folin-Phenol (Lowry) assay. Non-mitochondrial samples were diluted 2x in Laemmli sample loading buffer (SLB) and incubated at 95 °C for 1 min., while mitochondrial samples were diluted 2x in SLB containing 5x the standard concentration of SDS and incubated at 25 °C for 30 min. Samples were separated by SDS-PAGE (10% gels) and transferred to nitrocellulose, followed by probing with antibodies as recommended by manufacturer protocols. Detection employed HRP-linked secondary antibodies with enhanced chemiluimnescence (GE Biosciences). Developed ECL film images were quantified by densitometry using NIH ImageJ software (N=3-4 mice per genotype).
Body Composition, Fasting Glucose Response, and Electrocardiogram
84 day old (12 week) WT and littermate Kcnt2 -/male mice were anesthetized as described above, and body fat content measured using dual energy X-ray absorptometry (DEXA) scanning (Lunar PIXImus densitometer, GE, Fitchburg WI). Blood glucose was measured using a True2Go™ glucose meter with TrueTest™ glucose strips (Trividia Health, Fort Lauderdale FL). Mice were fasted overnight in cleaned cages with access to water and cotton bedding. Alternatively, after anesthesia mice electrocardiograms were recorded using a three electrode EKG amplifier (Harvard Apparatus, Cambridge MA). EKGs were averaged for each animal from ten different segments of the trace, each containing R 1 -S 1 -T 1 -P 2 -Q 2 -R 2 waves.
qPCR analysis
mRNA was extracted from heart homogenates with acid phenol/TRIzol according to the Direct-zol RNA MiniPrep Kit R2050 (Zymo Research, Irvine CA) as described (29) . cDNAs were prepared using an iScript kit (170-8891, BioRad). qPCR analysis was performed using a BioRad PrimePCR TM "Regulation of lipid metabolism-PPAR" M96 Predesigned 96-well panel for use with SYBR® Green (Cat # 10031585).
Replicates & Statistics
Numbers of individual replicates for experiments are listed in each figure legend. For samples comparing WT and Kcnt2 -/-, one "N" equals one animal (i.e., biological replicates). Statistical differences between WT and Kcnt2 -/were determined using two-way ANOVA with a Bonferroni correction for multiple testing, followed by post-hoc paired or non-paired t-tests (p<0.05 cut-off). Figure 1A shows the result of a genotyping experiment on WT and Kcnt2 -/mice, indicating the expected amplicons (see methods). The deletion targets exon 22 of the protein, and results in no residual protein in the knockouts (18), as we have also previously confirmed in the heart (3).
Results
Kcnt2 knockout
Cardiac Mitochondria Contain a K Na 1.2 Channel
To investigate cardiac mitochondrial K + channels, we performed electrophysiology studies on Percoll™purified isolated mitochondrial inner membranes (mitoplasts) from hearts of wild type (WT) or Kcnt2 -/mice (schematic, Figure 1C ). Mitochondrial enrichment was verified by western blotting for mitochondrial proteins, and purity was confirmed by western blotting for non-mitochondrial membrane proteins ( Figure 1D ). Mitoplasts were readily identified under light microscopy ( Figure 1C ) and high resistance seals (2-10 G→ ) were formed with the inner membrane opposite the outer membrane cap. In a preliminary series of experiments using attached mitoplast patch configuration, channel activity in WT was not activated by NaCl alone, but manifested upon further addition of the K Na activator bithionol (BT) (3) . No activation by NaCl or BT was seen in Kcnt2 -/mitoplasts ( Figure 1E /F). The absence of activation by NaCl alone in WT mitoplasts suggested that the channel's ion-sensing site may be on the matrix side of the inner membrane, and thus inaccessible to Na + from the bath perfusion on this time scale. To investigate such a channel, excised mitoplast patch was employed, affording access to the matrix side of the inner membrane ( Figure 1C ).
Channel activity was observed in a high proportion of independent preparations obtained from both WT (85%) and Kcnt2 -/-(76%) hearts (Figure 2A ), consistent with previous reports that mitochondria contain numerous K + channels (1, 30) . A multiple level screen was performed to triage recordings containing channels other than K Na 1.2 ( Figure 2B -D). The bath recording solution was sequentially switched from initial (containing 100 µM CaCl 2 ), to 40 mM LiCl, then 40 mM NaCl, and finally 40 mM NaCl plus 2.5 µM BT. Under each condition, channel activity was monitored at holding potentials from -100 mV to +100 mV.
First, patches exhibiting channel activity in Ca 2+ alone were discarded, as this is indicative of K Ca channel activity ( Figure 2B , gold). Next, we discarded patches exhibiting activity following the switch to LiCl, as this is indicative of Na + -conductance (31) ( Figure 2B , light gray). Next, patches exhibiting channel activity in the presence of activating levels of NaCl (40mM) and NaCl plus BT (2.5 µM) were considered potential K Na 1.2 candidates ( Figure 2C blue). Recordings exhibiting channel activity in the presence of Na + but not following BT addition, were also discarded ( Figure 2C dark gray). Finally, single channel unitary conductance was compared to expected values for K Na 1.2 (~140 pS) (15, 31, 32) and those patches exhibiting appropriate conductance were considered to be K Na 1.2 channels worthy of further analysis ( Figure 2D red). Figure 2E shows representative recordings observed in mitoplast patches from WT and Kcnt2 -/mice, exhibiting a variety of unitary conductances, with the knockouts having an absence of activity in the conductance range expected for K Na 1.2. Quantitation of all conductances showed a cluster of 6 channels in WT mitoplasts that passed all screens ( Figure 2F red data points), with no channels of similar conductance observed in Kcnt2 -/mitoplasts. The Kcnt2 -/recordings contained proportionally more Na + and BT activated channels than WT in the small conductance range ( Figure 2F , black symbols in 20-80 pS range, Kcnt2 -/-6 of 42 vs. WT 2 of 25). A similar observation has been made for a mitochondrial BK channel, wherein loss of the expected conductance in a knockout was accompanied by appearance of smaller conductances (12). Figure 2G shows representative examples of single channel activity for three (of six) Na + and BT activated conductances recorded at a holding potential of -40 mV in WT mitoplasts. As previously reported for K Na 1.2 (15), these channels showed rapid flickering between open and closed states. The average unitary slope conductance was 138±1 pS ( Figure 2H : peak conductance graph for all six channels). Under our buffer conditions, reversal potential for channels conducting Na + or Clis predicted to be -23 mV or -8 mV respectively. Since K + is the only other ion present, and the channel current crossed zero at -2 mV, this indicates that K + is the predominant conducting ion. Together, the data in Figure 2 demonstrate that WT cardiac mitochondria contain a K + channel with the ion-selectivity, ion-sensitivity, pharmacology and conductance properties of K Na 1.2, that is absent in mitochondria from Kcnt2 -/mice.
Electrophysiologic Characterization of Mitochondrial K Na 1.2
A detailed single channel analyses of all 6 assigned K Na 1.2 patches was not possible due to the presence of two or more identical channels within some patches ( Figure 3A ), suggesting that K Na 1.2 channels may cluster in their endogenous membranes. Such clustering has been previously reported for K Na 1.1 channels in neuronal plasma-membranes (33) . Examination of all suitable WT recordings (representative example Figure 3B) revealed a higher open probability at negative potentials ( Figure 3C ). In addition, as previously reported for K Na 1.2 (15, 35) , numerous distinct subconductances were apparent between 35 and 140pS ( Figure 3D ). This behavior is characteristic of K Na 1.1 channels (Kcnt1/Slack/SLO2.2) (34, 35) and while it has been observed in K Na 1.2 mutants (36), this is the first observation of such in WT K Na 1.2 channels in endogenous membranes. The average slope conductance when considering all subconductances was 75 pS ( Figure 3E ), which agreed well with the average chord conductance of 74.8±6.8 pS (assuming reversal potential = 0 mV). These data indicate that smaller subconductance states predominate in the active channel current.
Open and closed channel dwell times were also calculated from continuous recordings at -40mV (representative 45 s. example, Figure 3F ). The frequency of channel open and closed dwell times was fitted to the sum of multiple simple exponentials, constituting 94.6% of the total area under the curve, and subsequent log-binned histograms revealed peaks representing two open times and three closed times ( Figure 3G) . The longest closed time (→ 3 = 262 ms.) represents long periods of channel closure between bursts of activity, which is characteristic for K Na 1.2 (REF).
K Na 1.2 Channel Activation Uncouples Cardiomyocyte Oxidative Phosphorylation
We next sought to determine the impact of cardiac K Na 1.2 channel activity on cardiomyocyte bioenergetics. Using Seahorse™ extracellular flux (XF) analysis, we measured oxygen consumption rates (OCR) of cardiomyocytes from WT and Kcnt2 -/mice. Cells from both genotypes had similar viability and rodshaped morphology ( Figure 4A ). Figure 4B shows that the K Na opener BT (2.5 µM) significantly stimulated OCR in oligomycin-treated cardiomyocytes from WT mice but not those from Kcnt2 -/mice (WT: 370±48 Max OCR; Kcnt2 -/-154±32 Max OCR). The small effect of BT seen in Kcnt2 -/cells is consistent with the observation of the small conductances activated by Na + and BT in Kcnt2 -/mitoplast patches ( Figure 2F ).
In the mitochondrial K + cycle (37), K + entry to the organelle activates a mitochondrial K + /H + exchanger, such that mitochondrial K + channel activity can uncouple oxidative phosphorylation. As such, the much larger BT induced respiratory stimulation in WT vs. Kcnt2 -/cardiomyocytes is likely due to mitochondrial uncoupling. As an additional control, the bona-fide mitochondrial uncoupler FCCP elicited similar maximal respiration rates in cardiomyocytes from both genotypes WT: 387±15 Max OCR; Kcnt2 -/-364.2±53 Max OCR), rendering it unlikely that the differential effect of BT in WT vs. Kcnt2 -/cells was due to an underlying difference in overall bioenergetic capacity. Consistent with this, western blotting for a number of mitochondrial marker enzymes (SDHA, ICDH, Cyp-D, and ETFA) suggested no difference in mitochondrial mass or content between WT and Kcnt2 -/hearts ( Figure 4C ).
Loss of K Na 1.2 Mildly Impacts Cardiac Mitochondrial Ultrastructure
An important function of the mitochondrial K + cycle is the regulation of organelle volume (38, 39) , and K Na 1.2 activity is known to be sensitive to osmolarity (40, 41) . Thus we hypothesized that mitochondria from Kcnt2 -/may exhibit ultrastructural changes. Electron-microscopic analysis of hearts from WT and Kcnt2 -/mice ( Figure 4D -F) revealed that mitochondria had similar area (WT: 0.51±0.30 µm 2 , Kcnt2 -/-: 0.53±0.32 µm 2 , means±SD, N=3-4) and matrix density (WT: 109±13, Kcnt2 -/-: 102±11, means±SD, N=3-4). However, the distribution of these parameters ( Figure 4E ) suggests a small shift toward increased area and density in Kcnt2 -/vs. WT. Additionally, no difference in either form-factor or aspect-ratio was observed between genotypes ( Figure 4F ), indicating that K Na 1.2 deficiency does not alter mitochondrial fission or fusion (42, 43) . Together, the data in Figure 4 suggest that although activation of K Na 1.2 can uncouple respiration, loss of the channel does not impact cardiac mitochondrial structure or content.
K Na 1.2 is Required for Cardiac Respiratory Reserve Capacity when Oxidizing Fat
In an effort to further understand the bioenergetic effects of K Na 1. Figure 5B open bars) . In WT cells, a robust uncoupling response to FCCP was seen under all conditions, and notably the uncoupling response with palmitate alone (3.3 fold) was equal to that seen when both substrates were present (3.3 fold). However, in Kcnt2 -/cells, the uncoupling response with palmitate alone (2.4 fold) was significantly blunted compared to that seen when both substrates were present (4.3 fold) Figure 5B ). The additional OCR induced over baseline by FCCP is used to calculate RR capacity. Figure 5C shows that the RR of WT and Kcnt2 -/cells is similar in either the glucose alone or the glucose plus palmitate conditions (red and purple bars respectively). However, with palmitate alone (blue bars), Kcnt2 -/cells exhibit a significant RR deficit relative to WT.
(comparison between blue and purple bars in left & right panels of
Notably, no such RR deficit was observed in myocytes from Kcnt2 -/mice respiring on lactate, glutamine, galactose, or pyruvate ( Figure 5D ), indicating the Kcnt2 -/-RR deficit is specific to fat oxidation.
To test the physiologic relevance of this RR deficit, the ability of perfused hearts to respond to increased metabolic demand was tested. Hearts from WT and Kcnt2 -/mice were perfused with palmitate as the sole carbon source, while stimulating workload by addition of the → -adrenergic agonist isoproterenol (100nM).
Hearts from Kcnt2 -/mice showed a significantly reduced functional response to isoproterenol, relative to WT (WT: 213±20 % vs. Kcnt2 -/-: 159±13 %, means±SEM, N=7) ( Figure 6A ). However, consistent with the isolated cardiomyocyte OCR data ( Figure 5C ), no difference in the isoproterenol-induced functional response was observed when the perfusion buffer was supplemented with glucose and palmitate ( Figure 6A ). Together, these data suggest that loss of K Na 1.2 results in an impaired ability to respond to increased metabolic demand when oxidizing only fat. Consistent with previous reports (3, 18) no EKG differences were observed in Kcnt2 -/mice ( Figure 6B ), suggesting that loss of K Na 1.2 per se does not impact cardiac contractile function.
Whole Animal Metabolic Differences in Kcnt2 -/-Mice
Since the heart is an major fat-burning organ, we hypothesized that the fat-specific RR capacity deficit in Kcnt2 -/might be accompanied by metabolic perturbations at the whole animal level. No significant differences in weight gain were observed between WT and Kcnt2 -/mice over 25 weeks ( Figure 7A ). Analysis of percent body fat content by differential energy X-ray absorptometry analysis (DEXA, Figure 7B ) revealed a small difference in average fat content between genotypes (WT: 12.1±2.8 % vs. Kcnt2 -/-: 13.6±3.3 %), but nevertheless this difference was statistically significant between paired littermates ( Figure 7C ). In addition, while WT mice showed an expected drop in blood glucose following an overnight (15 hr.) fast, no such drop was seen in Kcnt2 -/mice ( Figure 7D ). This suggests elevated gluconeogenesis in response to fasting in Kcnt2 -/-, which is consistent with a potential increased reliance on glucose oxidation as a compensatory response to the fat-specific RR defect under stress conditions.
Metabolomic and Expression Profiling of Kcnt2 -/-Hearts
To investigate the molecular underpinnings of the fat-specific RR defect in Kcnt2 -/hearts, expression of metabolic regulatory genes was measured using a predesigned qPCR array ( Figure 8A , Table 1 ). No differences were observed between WT and Kcnt2 -/hearts, suggesting the fat-specific RR defect is not due to a remodeling of metabolism at the gene level. Separately, a small but non-significant decrease in energy charge (ATP+½ADP/(ATP+ADP+AMP)) was observed in Kcnt2 -/mice (WT: 0.87±0.05 vs. Kcnt2 -/-: 0.77±0.03, mean±SEM, N=5-6), suggesting that energy-sensing metabolic regulators such as AMP dependent protein kinase (AMPK) may be altered. However, western blotting analysis revealed no difference in AMPK phosphorylation between WT and Kcnt2 -/hearts (data not shown). Together with data in Figures 4 and 5 , these findings suggest that K Na 1.2 deficiency does not induce large scale remodeling of cardiac mitochondrial metabolism. Rather, K Na 1.2 loss specifically impacts cardiac fat oxidation, only under conditions of high energy demand such as uncoupling or → -adrenergic stimulation.
Finally, to understand the effects of K Na 1.2 deficiency on cardiac metabolism at a systems level, an unbiased metabolomics analysis was performed. Principal component analysis (PCA) showed no significant difference in the fundamental character of metabolism between WT and Kcnt2 -/hearts at baseline ( Figure 8B) .
A volcano plot for all 501 metabolites measured revealed only 10 were significantly altered (>1.5-fold vs. WT, p<0.05) ( Figure 8C ). Of these metabolites, notable changes were an increase in phenol-sulfate and decrease in dimethyl-sulfone, potentially indicating perturbations in aryl-sulfotransferase activity and sulfur metabolism.
Dehydroascorbate was significantly lower in Kcnt2 -/hearts, potentially indicating lower oxidative load. In addition, inositol-1-phosphate was significantly elevated, and a cluster of diacylglycerol metabolites was also elevated (although no individual DAG approached significance), suggesting enhanced phospholipase C activity in Kcnt2 -/-. Overall, the comparatively minor nature of metabolomic perturbations in Kcnt2 -/hearts at baseline is consistent with the notion that the impact of K Na 1.2 loss is limited to fat oxidation under conditions of high energy demand.
Discussion
A plethora of studies has identified mitochondrial K + channels at the phenomenological level (reviewed in (1, 44) ), and several studies have linked these channels mechanistically to protection against IR injury (1, (45) (46) (47) . However, surprisingly few examples exist of bona-fide mitochondrial K + channels that are: (i) identified at the molecular (genetic) level, (ii) characterized with robust electrophysiology, and (iii) linked to any specific mitochondrial channel function phenotype (examples include K Ca 1.1 (11, 12), K ATP (10), and SK3 (48)). While the phenomenon of a K Na channel was first characterized in hearts thirty years ago, the field of K Na research rapidly transitioned to study of these channels in brain (19) . As such, very little is known about role of K Na in cardiomyocytes, including sub-cellular localization. Using patch-clamp studies of isolated cardiac mitochondrial inner membranes, we recorded a K + channel matching the known characteristics of K Na 1.2 (ionsensitivity, ion-selectivity, pharmacology and conductance) in mitoplasts from WT mice, that was absent in those from Kcnt2 -/mice (Figures 1-3) . This is the first report of a K Na channel in mitochondria.
Since cardiac mitochondria are reported to contain several cation and anion channels (49, 50) , mitoplast recordings were subjected to a rigorous screening process to ensure that conductances assigned as K Na 1.2 did not originate from other channels. Bath/pipette ratios of the major ion components (K + , Na + , and Cl -) enabled reversal potentials to be differentiated. The Na + surrogate Li + was used to screen out any Na + -activated currents that were in fact due to Na + conductance. In addition, any conductances activated by Ca 2+ were dismissed, to ensure patched membranes were free of K Ca channels. Anion channels of the IMAC and CLIC variety exhibit conductances (~100pS: IMAC, ~8pS: CLIC4) sufficiently distinct from K Na 1.2 that, in combination with the observed reversal potential, we are confident do not contribute to assigned K Na conductances. Similarly mitoK ATP channels (~10pS) would not be mistaken for K Na 1.2. Finally, K Na 1.2 activation is significantly enhanced by Clin the presence of activating Na + , hence Clsalts were used to maximize the probability of detecting these channels (15). Of 25 recordings in WT mitoplasts, this strategy yielded 6 channels, a 24% success rate. Application of this rate to the 42 recordings in Kcnt2 -/mitoplasts predicts 10 such channels, but we observed zero.
Several known electrophysiologic characteristics of K Na 1.2 channels were also observed in our assigned K Na 1.2 mitoplast recordings, including: (i) multiple sub-conductance states ( Figure 3D) Figure 3A) (36) . In combination with the absence of such conductances in Kcnt2 -/mitoplasts, these characteristics strengthen the conclusion that the genetic origin of the channels herein assigned as mito-K Na 1.2, is the Kcnt2 gene product. Whole mitoplast attached patch experiments ( Figure 1E ) suggest that the orientation of the channel in the mitochondrial inner membrane is the same as that reported for plasma membrane K Na 1.2, namely with the c-terminal Na + sensing site on the inside of the membrane (15, 52).
Patches from WT and Kcnt2 -/recordings contained channels with a similar overall range of conductances. However, the distribution of these conductances between genotypes was shifted. In particular, channels with unitary conductances in the range of 20-80pS were more frequently observed in Kcnt2 -/-( Figure   2F ). A similar observation was recently made using a cardiac-specific knockout of the mito-BK channel (12), raising the intriguing possibility that loss of one mitochondrial K + channel may lead to compensatory upregulation of other channels, to maintain K + homeostasis. Given the importance of the mitochondrial K + cycle for the regulation of organelle volume (37) , such compensatory K + fluxes may account for the persistence of a small but non-significant respiratory uncoupling effect of BT in Kcnt2 -/cardiomyocytes ( Figure 4B) , as well as the relatively minor effect of K Na 1.2 loss on mitochondrial ultrastructure ( Figure 4D-F ). An alternative to compensatory expression between different mitochondrial K + channels, is the possibility they may form heteromers. Indeed, individual K Na 1.1 (Kcnt1) subunits can combine with K Ca 1.1 (Kcnma1) subunits to form functional heterotetramers of intermediate conductance and activation properties (14). Heterotetramers of K Na 1.1 with K Na 1.2 have also been demonstrated (36) . However, the existence of K Ca 1.1/K Na 1.2 heterotetramers has not been reported.
A key aspect of these studies was the discovery that loss of cardiac K Na 1.2 results in a unique metabolic phenotype, namely a specific defect in cardiac fat oxidation only under conditions of high energy demand. An important caveat is that we cannot currently rule out the possibility that the metabolic phenotype of Kcnt2 -/is due to loss of the channel at the plasma membrane. However, evidence for the existence of K Na channels at the cardiac plasma membrane comprises a single study 30 years ago (19) . Despite the development of anti-K Na antibodies, fluorescent tags, and K Na channel knockout animals, confirmation of the channel's existence at the cardiac plasma membrane has not been confirmed using any of these methods during the intervening time period. Coupled with definitive data herein demonstrating existence of K Na 1.2 in mitochondria, and previous reports of a BT activated mitochondrial K + channel that is absent in mitochondria isolated from Kcnt2 -/-, we assert that the most likely explanation for a mitochondrial/metabolic phenotype in Kcnt2 -/-, is loss of the channel in mitochondria.
The metabolic phenotype of Kcnt2 -/- (Figures 5-6 ) was manifest under conditions corresponding to classical bioenergetic "state 3", wherein the mitochondrial membrane potential is consumed to generate ATP.
As such, if the in-situ reversal potential of mitochondrial K Na 1.2 is above zero, then channel opening could readily occur under conditions of high energetic demand when potential is lowered. In addition, the mitochondrial membrane potential is known to "flicker" in-vivo (53) , such that transient depolarization events may activate mito-K Na 1.2. These properties may render mitochondrial K Na 1.2 function important under conditions of stress, such as tissue ischemia. Given the previously reported requirement of K Na 1.2 for cardioprotection by APC (3), it is notable that the mitochondrial membrane potential depolarizes and cytosolic Na + levels also rise during ischemia (54, 55) . Together, these observations suggest that mito-K Na 1.2 channels may be activated by acute perturbations in mitochondrial energy demand or under stress conditions such as ischemia. Such properties may explain why the metabolic phenotype of Kcnt2 -/is only evident under stress.
The data in Figure 7 revealed additional chronic effects of K Na 1.2 loss on bioenergetics that resulted in altered body fat content and fasting glucose metabolism. Due to the presence of a mitochondrial K + /H + exchanger (KHE), activation of a mitochondrial K + channel would be expected to decrease the mitochondrial → pH, thus uncoupling oxidative phosphorylation and stimulating OCR, as shown in Figure 4B . As such, mild mitochondrial uncoupling by mito-K Na 1.2 channel activators may represent a novel therapeutic avenue for obesity/diabetes/metabolic-syndrome. It is therefore notable that the anti-helminthic drug niclosamide, which activates K Na channels (56) , has long been known to uncouple mitochondria (57) , and was recently shown to confer benefits in a mouse high-fat diet model of diabetes (58) . Furthermore, a recent case report highlighted a patient with a K Na 1.2 mutation (Q 270 E) suffering from migrating focal seizures that were non-responsive to the ketogenic diet typically used to treat such symptoms (59) . Cardiac metabolomics also revealed a potential upregulation of phospholipase C (PLC) signaling in the Kcnt2 -/heart ( Figure 8C ). Since K Na 1.2 channels are known to interact with the PLC substrate PIP 2 (60) , this raises the possibility that loss of K Na 1.2 results in perturbation of PIP 2 /PLC signaling. An important PLC downstream target is protein kinase C epsilon (PKC → ), which is known to play a role in development of insulin resistance in response to a high fat diet (61) . As such, in addition to mitochondrial uncoupling, mito-K Na 1.2 channel activators may confer metabolic benefits via a PIP 2 /PLC/PKC → signaling axis. A deeper investigation of the relationship between mito-K Na 1.2 activity and metabolic regulation is thus warranted.
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(H) Channel current vs. voltage plot of peak unitary conductances of all K Na 1.2 channels from WT mitoplast recordings. Average slope conductance was 138±1 pS. Cardiac function data (heart rate x pressure product, RPP) for isolated perfused hearts from WT or Kcnt2 -/mice, perfused with Krebs-Henseleit (KH) buffer containing palmitate as the sole metabolic substrate. Bar below the trace indicates duration of 100 nM isoproterenol infusion. Graph shows RPP as a % of the average baseline value for 1 min before isoproterenol infusion. Inset bar graph shows comparison of the peak response to isoproterenol under this substrate condition (palmitate only, blue). Adjacent inset (right) shows the peak response to isoproterenol from a separate series of perfusions in which the KH buffer contained both palmitate and glucose as substrates (purple). Data are means ± SEM, N=7, *p<0.05 between genotypes. (B) EKG parameters obtained in-vivo from avertin-anesthetized WT and Kcnt2 -/mice. R-R' = distance between R waves of each beat (i.e., 1/HR), P = p-wave duration. P-R = interval between P and R waves. QRS 1 & QRS 2 = diameter of QRS complex (different calculation algorithms). Q-T = interval between Q and peak of T wave. Q-T max = interval between Q and end of T wave. Q-T corr = QT interval corrected for heart rate). Data are ± SD, N=4-5 animals. 
